Supplementary Tables S1-S12 from Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma
Liem Phan(The University of Texas MD Anderson Cancer Center), Mouhammed Amir Habra(The University of Texas MD Anderson Cancer Center), Siyuan Zheng(Third Affiliated Hospital of Guangzhou Medical University), Guermarie Velázquez-Torres(The University of Texas MD Anderson Cancer Center), Mong‐Hong Lee(Sun Yat-sen University), Christopher G. Wood(Massachusetts Eye and Ear Infirmary), Gilbert J. Cote(BC Cancer Agency), Levent Ozsari(The University of Texas MD Anderson Cancer Center), Camilo Jiménez(The University of Texas MD Anderson Cancer Center), Kanishka Sircar(McGill University), Enrique Fuentes‐Mattei, Sai‐Ching J. Yeung(The University of Texas MD Anderson Cancer Center), Lance C. Pagliaro(The University of Texas MD Anderson Cancer Center), Weixin Wu, Tao Hai(Guizhou University), Roeland Verhaak(Broad Institute), María Angélica Cortez(The University of Texas MD Anderson Cancer Center), Marie‐Claude Hofmann(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin
|Nature|1994|896
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665